Acne Medication Market is Projected to Grow at A CAGR of 4.4% During, 2020-2026

ABOUT THIS REPORT

OVERVIEW

Acne Medication Market was valued at $8,462.12 million in 2019 with a CAGR of 4.4% from 2020 to 2026.

Acne is a chronic skin condition that causes pimples and spots on the face, neck, chest, shoulders, back, and upper arms. Acne medications reduce oil production, fighting bacterial infection, speeding up skin cell turnover, and reducing inflammation. Acne medications include topical retinoid & combination retinoid, oral retinoid (Isotretinoin), topical antibiotic & combination antibiotics, oral antibiotics, salicylic acid, benzoyl peroxide, and others.

Increasing regulatory approval of acne medication is driving the global acne medication market. For instance, The U.S. Food and Drug Administration (FDA) has approved ARAZLO (tazarotene) Lotion from Bausch Health Companies Inc. ARAZLO is a topical treatment of acne vulgaris for patients nine years and older. ARAZLO is the first tazarotene acne treatment in a lotion form. Additionally, the U.S. Food and Drug Administration (FDA) has approved AMZEEQ (minocycline) topical foam by Foamix Pharmaceuticals Ltd. AMZEEQ was formerly known as FMX101, indicated for the treatment of moderate to severe acne vulgaris in pediatric and adult patients nine years of age and older. AMZEEQ is the first topical minocycline to be approved by the FDA for any conditions. Further, the rising prevalence of acne is a key factor in boosting the market. According to the World Health Organization (WHO), globally, acne affected more than 633 million people, making it the most common disease worldwide. More than 90% of the world population is affected by acne at some point in their life.

Topical Retinoid & Combination Retinoid, Oral Retinoid (Isotretinoin), Topical Antibiotic & Combination Antibiotics, Oral Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others is the type segment of the market scope. By application, the market is divided into Prescription Medicine and Over-the-counter (OTC) Medicine. The report covers the value of the global market by type and application.

Topical Retinoid & Combination Retinoid had shown significant growth in 2019, owing to the increasing clinical studies on a topical retinoid, awareness program for acne treatment, the partnership between companies to develop and supply topical retinoid, and the commercialization of regulatory approved topical retinoid.

North America, Europe, Asia Pacific, South America, and Middle East & Africa are taken into consideration at the global acne medication value figures. While North America is further categorized into enhancing the United States, Canada, and Mexico, Europe is split into the United Kingdom, Germany, France, Italy, and Rest of Europe. Asia-Pacific covers India, China, Japan, South Korea, and Rest of Asia Pacific in its scope. South America is bifurcated into Brazil, Argentina, and Rest of South America, with Middle East & Africa involving GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the global acne medication market in 2019, due to the rising prevalence of acne in North American countries. Moreover, rising awareness of acne medication in the U.S and increasing clinical studies on acne medications are some of the factors boosting the market growth.
Major players operating in the acne medication industry include Galderma S.A., Allergan Plc, Mylan N.V., Johnson & Johnson, Mayne Pharma Group Limited, Sun Pharmaceutical Industries Limited, Valeant Pharmaceuticals International, Inc., Teva Pharmaceutical Industries Ltd., Foamix Pharmaceuticals, and Daiichi Sankyo Company, Ltd.

The commercialization of regulatory approved acne medication, increasing clinical studies on acne medication, a rising awareness program for acne, and the partnership between companies to develop, regulatory approval and market acne medication are some of the strategies adopted by the major companies.